Patient Wait Time for a Family Practice Appointment: 15 Major US Cities Surveyed
Average patient wait time for a nonemergent appointment with an FP decreased between 2017 and 2020, according to a Merritt Hawkins survey. Is that a good sign?
Hypertension-related CVD Most Common ED Presentation in the US
Approximately one-third of CV-related ED visits are for hypertension-related conditions, including 13% for essential hypertension among women.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 21, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
USPSTF: Primary Care Clinicians Should Screen Adults for Anxiety, Depression
USPSTF's draft statement is the first it has issued recommending primary care screening for adults younger than 65 who do not have signs or symptoms of anxiety or depression.
Intervention Reduces Aspirin Use in Patients with AF, VTE Taking Warfarin, Improves Outcomes
An aspirin deprescribing intervention at anticoagulation clinics led to a 50% reduction in use among patients with AF, VTE prescribed warfarin.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 20, 2022
Semaglutide 2.4 mg: Weight Loss in Real-world Study Matches STEP Trial Program Findings
Semaglutide prescribed in clinical practice helped more than half of study participants achieve weight loss of ≥10% at 6 months.
Phase 3 Trial Now Underway of Investigational mRNA-based Influenza Vaccine
Pfizer announced that the first participants have been dosed in a novel phase 3 efficacy clinical trial of its quadrivalent modified RNA influenza vaccine candidate.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 19, 2022
Study: At-home COVID-19 Tests Less Effective After Omicron Emergence
The performance of 3 commercially available COVID-19 home-testing kits worsened during the emergence of the omicron variant, according to a new cross-sectional study.
Seen in the ED: Headache Following Bush Encounter
A 20-something man presents to the ED complaining of a headache after crashing a motorized scooter. Review the head CT. What's your Dx?
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 16, 2022
"Long COVID is Not Anxiety," but that Was an Early Hypothesis
Long COVID is now recognized as real, in the medical community and in Washington, DC, but 2 years ago it was a different story, says AAPM&R's Steven Flanagan, MD.
Percentage of Americans Receiving Mental Health Treatment Rose during Pandemic, New NCHS Data Brief Shows
New research shows that the percentage of adults who had received any mental health treatment in the past year increased by nearly 5% from 2019 to 2021.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 15, 2022
Tirzepatide Reduces Time to HbA1c Targets by Up to 3 Months vs Semaglutide, Insulin Degludec
Tirzepatide in an exploratory analysis of SURPASS-2 and -3 trials added proof of shorter time to glycemic targets and weight loss goals to superior reduction of HbA1c.
The Brunt of the Long COVID Patient Burden May Fall on Primary Care, says Rehabilitation Medicine Expert
NYU Langone Rusk Rehabilitation medical director Steven Flanagan, MD, discusses the "second crisis" of the pandemic and the impact on primary care.
COPD: Pulmonary Rehab is Effective Regardless of Inhaled Triple Therapy Use
In-hospital pulmonary rehabilitation improves function and symptoms in COPD patients whether they are on triple therapy or not, a new study confirms.
Arthritis in Older Adults: Patient Thoughts on Symptoms, Management, & Clinician Counseling
New findings from a national survey shed light on patient attitudes and experiences with arthritis and joint pain.
Finerenone: FDA Expands Label to Include Cardiovascular Outcomes Trial Data
Data from the pivotal phase 3 FIGARO-DKD cardiovascular outcomes trial with finerenone reaffirms the agent's dual cardiorenal risk reduction benefits in T2D-associated CKD.
